Skip to main content
. 2020 Dec 8;21(24):9337. doi: 10.3390/ijms21249337

Figure 5.

Figure 5

The first data part of the left ventricular cardiac function assessment by invasive hemodynamic analysis performed two weeks after the last doxorubicin injection (i.e., at the end of the experimental protocol) in normotensive, transgene-negative Hannover Sprague-Dawley (HanSD) and hypertensive, Ren-2 transgenic (TGR) rats. Left ventricle peak pressure (A), left ventricle end-diastolic pressure (B), left ventricle end-diastolic volume (C), maximum rates of pressure rise (+dP/dt)max (D), maximum rates of pressure fall (−dP/dt)max (E), relaxation constant tau (F). * p < 0.05 compared with untreated animals of the same strain. The values are means ± SEM.